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Abstract Various biomaterials have been proposed to build up scaffolds for promoting neural 
repair. Among them, chitosan, a derivative of chitin, has been raising more and more 
interestamongbasicandclinicalscientists.Anumberofstudieswithneuronalandglial cellcultures 
haveshownthat thisbiomaterial has biomimetic properties,which make it a good candidate for 
developing innovative devices for neural repair. Yet, in vivo experimental studies have shown that 
chitosan can be successfully used to create scaffolds that promote regeneration both in the 
central and in the peripheral nervous system. In this review, the relevant literature on the use of 
chitosan in the nervous tissue, either alone or in combination with other components, is 
overviewed. Altogether, the promising in vitro and in vivo experimental results make it possible to 
foresee that time for clinicaltrialswithchitosan-basednerveregeneration-
promotingdevicesisapproaching quickly. 
1. INTRODUCTION 
Chitin and its main derivative, chitosan, are becoming increasingly relevant among the novel 
families of biomacromolecules because of their wide potential application in biomedicine and 
tissue engineering (Domard & Domard, 2002; Khor & Lim, 2003; Kumar, 2002; Singh & Ray, 2000; 
Suh & Matthew, 2000). Chitin and chitosan represent a family of linear polysaccharides made up 
of b(1–4)-linked N-acetyl D-glucosamine and D-glucosamine units (Domard &Domard, 2002; 
Muzzarelli, 1977).Dependingon the processing method used to derive the biopolymer, 
glucosamine units may be randomly or block distributed throughout the biopolymer chain. Chitin 
is primarily obtained from the exoskeleton of arthropods, shellfish such as crabs and shrimps, 
cuticles of insects, and cell wall of fungi (Muzzarelli, 1977). Based on the chain organization in 
sheets or stacks, chitin can be classified into three crystalline isoforms: a, b, and g. The structure of 
a-chitin has been investigated more extensively than that of either the b or the g form, because it 
is the most common polymorphic form. Commercial chitins are usually isolated from marine 
crustaceans, because of large amount of waste derived from food processing. In this case, a-chitin 
is produced while squid pens are used to produce b-chitin (Aranaz et al., 2009). Crustacean shells 
consist of proteins, calcium carbonate, chitin, and contain pigments such as carotenoids. Chitin is 
extracted by acid treatment to dissolve the calcium carbonate followed by alkaline extraction to 
dissolve the proteins and by a depigmentation step to obtain a colorless product (Aranaz et al., 
2009; Muzzarelli, 1977). Chitosan, on the other hand, although occurring in some fungi 
(Mucoraceae), is produced industrially by cleavage of the N-acetyl groups of the chitin N-acetyl D-
glucosamine residues (Muzzarelli, 1977).  
Chitosan is prepared by alkaline hydrolysis of acetamide groups of chitin. High temperature (100 
C) combined with strong aqueous alkali treatments are used to deacetylate chitin (N-acetylation 
degree lower than 30%), in order to obtain chitosan. Two different methods of preparing chitosan 
from chitin with varying degrees of acetylation are known: heterogeneous deacetylation of solid 
chitin and homogeneous deacetylation of preswollen chitin under vacuum in an aqueous medium 
(Aranaz et al., 2009; Muzzarelli, 1977). The main limitations in the use of chitosan in several 
applications are its high viscosity and low solubility at neutral pH. Different experimental variables 
should be taken into account when working with chitosan solutions such as the nature of the salt 
counterion, length of polymer chain, molecular weight (Mw), pH, ionic strength, the addition of a 
nonaqueous solvent, and the degree of N-acetylation (Aranaz et al., 2009; Muzzarelli, 1977). Their 
different solubilities in dilute acids are commonly used to distinguish between chitin and chitosan. 
Chitosan, the soluble form, can have a degree of acetylation between 0% and about 60%, the 
upper limit depending on parameters such as processing conditions, molar mass, and solvent 
characteristics (Aiba, 1992). Thanks to the protonation of free amine groups present along the 
chitosan chain; this macromolecule can be dissolved in diluted aqueous acidic solvents, rendering 
the corresponding chitosan salt in solution. Degradation rate can be tuned based on its degree of 
deacetylation (DD), whereas fully deacetylated (DD¼100%) chitosan is nondegradable (Freier, Koh, 
Kazazian, & Shoichet, 2005; Tomihata & Ikada, 1997) and partially deacetylated (DD¼70%) 
chitosan is fully degradable (Tomihata & Ikada, 1997). Chitin and chitosan are interesting 
candidates for use in the medical and pharmaceutical applications because they have positive 
properties such as biocompatibility, biodegradability, and nontoxicity that make them suitable in 
biomedical field (Khor & Lim, 2003). Moreover, other properties such as analgesic effect, 
antitumor activity, hemostatic, anticholesterolemic, antimicrobial, permeation enhancing effect, 
and antioxidant properties have also been reported (Kumar, Muzzarelli, Muzzarelli, Sashiwa, & 
Domb, 2004). Several chitosan products have been approved by the Food and Drug 
Administration. Furthermore, chitosan has been used to generate laseractivated film surgical 
adhesive (SurgiLux) that can be very useful as an alternative to microsurgery for peripheral nerve 
reconstruction (Foster & Karsten, 2012). SurgiLux has been tested in vitro and in vivo on different 
tissues including nerve, intestine, dura mater, and cornea, demonstrating a good biocompatibility 
(Foster & Karsten, 2012). 
The American Society of Testing Materials (ASTM F04 division IV) is making efforts to establish 
standard guidelines for tissue engineered medical products (ASTM, 2001). The F2103 guide covers 
the evaluation of chitosan salts suitable for use in medical applications. Moreover, chitosan 
hydrochloride (a derivative of chitosan) has been included in the European Pharmacopeia in 2002 
(Pharmacopeia, 2002). In order to be approved as a biomedical material, sterility is an important 
issue to resolve. Chitosan products intended for parenteral administration andthosein 
contactwithserousfluids, forexample,wounds,haveto besterilized before use. Common methods 
for the sterilization include exposure to dry heat, saturated steam, ethylene oxide, or g radiation. 
Before using any of these methods for chitosan product sterilization, their effects on polymer 
properties and end performance have to be tested, as they can cause irreversible damage to the 
morphological, physical, mechanical, and biological characteristics. Dry heat sterilization method 
resulted in lower aqueous solubility for chitosan and in insolubility in acidic aqueous media (Lim, 
Khor, & Ling, 1999). Saturated steam and g irradiation caused an acceleration in the rate and 
extent of chitosan chain scission events, respectively. The use of 70% ethanol, as a sterilizing 
agent, is a suitable method as it did not alter chitosan-membrane characteristic; however, it is 
limited to small-scale applications. Ethylene oxide is a simple technique to be used for sterilization 
of industrially produced chitosan membrane, preserving chitosan-membrane morphology, 
percentage of strain at break, and in vitro cytotoxicity to Vero cells. Moreover, this method can be 
used for industrial sterilization of chitosan membrane (Marreco, da Luz Moreira, Genari, & 
Moraes, 2004). The long-term storage may have effects and implications on the integrity of chitin 
and chitosan materials (Kam, Khor, & Lim, 1999), and further investigation is needed to optimize 
sterilization and storage method conditions. It has been shown that chitosan is capable of forming 
large phospholipid aggregates by inducing the fusion of small dipalmitoyl phosphatidylcholine 
bilayers, which are a major component of the plasma membrane (Pavinatto et al., 2007; Zuo et al., 
2006). Thus, the use of chitosan as a “fusogen” might be more advantageous as a potential clinical 
tool relative to nonionic polymers (e.g., PEG or P188). Due to its high biodegradability and 
biocompatibility,togetherwithitsspecific interactions with components of the extracellular matrix 
(ECM) and growth factors, chitosan employment is growing in a variety of applications, including 
implantable and injectable orthopedic and periodontal lsystems,drug delivery systems, wound-
healing agents, lung surfactant additives, and tissue engineering scaffolds for tissue regeneration 
of skin, bone, and cartilage (Drury & Mooney, 2003; Gan & Wang, 2007; Janes, Fresneau, 
Marazuela, Fabra, & Alonso, 2001; Madihally & Matthew, 1999; Roy, Mao, Huang, & Leong, 1999; 
Suh & Matthew, 2000; Ueno et al., 1999; Yuan, Zhang, 
Yang,Wang,&Gu,2004;Zuoetal.,2006).Yet,chitosanisaversatilematerial 
currentlyusedinclinicalwounddressings,primarilyforitshemostaticproperty (Gustafson, Fulkerson, 
Bildfell, Aguilera, & Hazzard, 2007). Another important application of chitosan is the development 
of drug delivery systems such as nanoparticles, hydrogels, microspheres, films, and tablets. The 
abundance of primary amine groups enables chitosan to be ionically or covalently coupled to 
various biomolecules because the amine moieties become predominantly protonated and 
positively charged below pH 6.5, whereas they are increasingly deprotonated at pH 6.5 and above. 
As a result of its cationic character, chitosan is able to react with polyanion giving rise to 
polyelectrolyte complexes (Acosta, Aranaz, Peniche, & Heras, 2003; Peniche, Arguelles-Monal, 
Peniche, & Acosta, 2003). Moreover, due to its positive charge, chitosan can interact with negative 
molecules such as DNA. This property has been used to prepare a nonviral vector gene delivery 
system (Mumper, Wang, Claspell, & Rolland, 1995). Among the different tissue organs, many 
studies have investigated the use of chitosan for repair, not only because of its biocompatibility, 
biodegradability, low toxicity, and cost but also because of its excellent potential for supporting 
three-dimensional organization of regenerating tissues (Evans et al., 1999; Ho et al., 2005; Ma et 
al., 2003; Madihally & Matthew, 1999; Novikova, Novikov, & Kellerth, 2003; Vasconcelos & Gay-
Escoda, 2000). Here, we review the main chitosan-based bioengineering strategies for peripheral 
nerve and spinal cord injury (SCI) repair. This review has been divided into the following sections: 
in the first part, we report in vitro studies on the evaluation of chitosan properties, the second and 
the third parts cover in vivo studies for spinal cord and peripheral nerve repairs, respectively. 
2. IN VITRO EVIDENCE: CHITOSAN PROPERTIES, BIOCOMPATIBILITY, AND SURFACE 
MODIFICATION  
2.1. Chitosan physical properties  
2.1.1 Mechanical strength 
Chitosan matrices have been shown to have low mechanical strength under physiological 
conditions (Itoh et al., 2003; Madihally & Matthew, 1999) and to be unable to maintain a 
predefined shape for transplantation, which has initially limited their use as nerve guidance 
conduits (NGC; Freier, Montenegro, Koh, & Shoichet, 2005; Itoh, Suzuki, et al., 2003; Itoh et al., 
2003; Yamaguchi, Itoh, Suzuki, Osaka, & Tanaka, 2003). To improvechitosan 
mechanicalproperties,Ao et al.(2006) useda novel mold and thermally induced phase-separation 
technique with a unidirectional temperature gradient to produce chitosan conduits containing 
longitudinally aligned microfibers. This preparation method may allow the incorporation of 
therapeutic agents into the matrix for sustained release, as no toxic substances have been used 
(Ao et al., 2006). In vitro characterization using Neuro-2a-cells verified that the mold-based 
multimicrotubule chitosan conduit had suitable mechanical strength, microtubule diameter 
distribution, porosity, swelling, biodegradability, and nerve cell affinity, for applications in nerve 
tissue engineering (Ao et al., 2006). A novel method to create poroustubular chitosan scaffolds 
with desirable mechanical proprieties and controllable inner structure has been developed by 
Wang et al. (2006). Inner matrix, with multiple axially oriented macrochannels and radially 
interconnected micropores, was produced using acupuncture needles as mandrel during the 
molding process (Wang et al., 2006). In vitro characterization demonstrated that the scaffolds 
possessed suitable mechanical (porosity, swelling, and biodegradability) and biological 
(differentiated Neuro-2a cells grew along the oriented macrochannels) properties for applications 
in nerve tissue engineering (Wang et al., 2006). However, these scaffolds have a low mechanical 
strength under physiological conditions, thus limiting their applicability. In order to increase 
mechanical strength, chitosan conduits have been reinforced with additives (Yang et al., 2004) or 
cross-linked with chemical substances such as formaldehyde (Wang et al., 2005). Recently, a mold-
casting/lyophilization method was used to fabricate porous chitosan nerve conduits; however, 
these conduits still have a low mechanical strength under physiological conditions. The porous 
structure of the chitosan conduit was reinforced by introducing braided chitosan fibers, leading to 
an increase in tensile strength (Wang et al., 2007). These conduits were permeable to molecules 
ranging in molecular size from 180 to 66,200 Da (Wang et al., 2007). Moreover, in vitro direct 
contact cytotoxicity test, using Neuro-2a cells, showed that the conduits were not cytotoxic (Wang 
et al., 2007). While chitosan has low mechanical strength under physiological conditions 
(Madihally & Matthew, 1999; Yamaguchi et al., 2003; Yang et al., 2002), chitin gels prepared by 
selective N-acetylation of chitosan amine groups (Hirano, Ohe, & Ono, 1976) are known to be 
mechanically strong (Vachoud & Domard, 2001), suggesting that they may be able to overcome 
the insufficient strength described for chitosan-based NGCs. Chitosan hydrogel tubes have been 
fabricated from chitosan solution using acylation chemistry and mold-casting techniques followed 
by alkaline hydrolysis that results in chitosan tube formation, with the extent of hydrolysis 
controlling the resulting amine content (Freier, Montenegro, et al., 2005). Chitosan tubes resulted 
to be mechanically stronger to support adhesion and differentiation of primary chick dorsal root 
ganglion neurons and to significantly enhance neurite outgrowth (Freier, Montenegro, et al., 
2005). Also, the DD affects chitosan mechanical properties, and it has been shown that the 
swelling index of chitosan films decreases and the elastic modulus and tensile strength increase 
with the increase in DD (Wenling et al., 2005). Finally, Wang et al. showed that a bilayered 
chitosan mesh tube, with an inner layer of oriented nanofibers and an outer layer of random 
nanofibers, increased the resistance to the compression force compared with the random fiber 
mesh tubes (Wang, Itoh, Matsuda, Ichinose, 2008; Wang et al., 2008). 
2.1.2 Porosity 
Porosity of a regenerative scaffold is an important factor in tissue engineering. Huang et al. 
described an easy method for the production of longitudinally oriented channels made of chitosan 
by using a lyophilizing and wire-heating process. Ni-Cu wires were used as a mandrel because of 
their high level of resistance (Huang, Huang, Huang, & Liu, 2005). In comparison with poly-lactic-
co-glycolic acid (PLGA), the permeability and porous structure of chitosan improved its 
effectiveness for the nerve tissue engineering (Huang, Onyeri, Siewe, Moshfeghian, & Madihally, 
2005). The employ of a weak base, to neutralize chitosan, can be used to influence the porous 
structure, making it more uniform (Huang, Onyeri, et al., 2005). Porosity geometry can also be 
controlled by a production method based on inverted colloid crystals (Kuo & Lin, 2013). 
2.1.3 Chitosan biodegradability 
 Concerning biodegradability, chitin and chitosan are degraded in vivo by proteasespresentin 
allmammaltissues,suchaslysozyme, papain,andpepsin, leading to the release of nontoxic 
oligosaccharides of variable length which can be incorporated into glycosaminoglycans and 
glycoproteins (Pangburn, Trescony, & Heller, 1982). The length of the chains also affects the 
degradation rate (Huang, Khor, & Lim, 2004; Tomihata & Ikada, 1997; Zhang & Neau, 2001). 
Controlling degradation rate of chitin- and chitosan-based biopolymers is essential in drug delivery 
and tissue regeneration applications. The degradation rate also affects the biocompatibility as fast 
degradation rate results in amino sugars accumulation that may lead to inflammatory response. 
Chitosan samples with low DD may induce an inflammatory response, whereas chitosan samples 
with high DD do not because of the low degradation rate (Hirano, Tsuchida, & Nagao, 1989; Kurita, 
Kaji, Mori, & Nishiyama, 2000; Sashiwa, Saimoto, Shigemata, Ogawa, & Tokura, 1991). The 
degradation rate of chitosan can be influenced by physical parameters such as porosity, fiber 
diameter, blending with other polymers, or the use of cross-linking agents. Chitosan scaffolds with 
high porosity degrade faster than scaffolds with smaller pore diameter. Within the same range of 
porosity, scaffolds with smaller pore diameter degrade faster (Cunha-Reis et al., 2007). Adjusting 
the pH of the solution of a nerve conduit has been reported to influence degradation properties. 
In particular, increasing the layer numbers and overcoming the acidity-caused autoacceleration of 
poly-D, L-lactic acid/ chondroitin sulfate/chitosan (PDLLA/CS/CHS) nerve conduit decrease its 
biodegradability rate retaining its integrity up to 3 months (Xu, Yan, Wan, & Li, 2009). The 
degradation kinetics is inversely related to the crystallinity degree which can be controlled by 
acting on the DD and on the distribution of acetyl groups. The absence of acetyl groups or their 
homogeneous/random distribution results in low enzymatic degradation rates (Aiba, 1992; Suh & 
Matthew, 2000). Chitosan nano-/microfiber meshes with a deacetylation of 78% have a faster 
biodegradation rate than meshes with a deacetylation of 93% and collapse over the time, causing 
occlusion of the tube made from these meshes (Wang, Itoh, Matsuda, Ichinose, et al., 2008). 
Degradation of chitosan films with very low (about 0.5%) or high (about 99.2%) acetylation is 
minimal over 4-week period, whereas progressive mass loss to greater than 50% has been 
reported for chitosan film with 30–70% acetylation (Freier, Koh, et al., 2005). Blending of chitin 
with other biomaterials like gelatin results in a faster degradation rate and significant loss of 
material compared with chitosan alone (Huang, Onyeri, et al., 2005).  
Finally, the use of cross-linking agents such as hexamethylene diisocyanate (HDI), epichlorohydrin 
(ECH), and glutaraldehyde (GA) may also result in significant decrease in degradation rate 
compared with noncross-linked chitosan (Cao et al., 2005). 
2.2. Chitosan biocompatibility  
Biocompatibility properties of chitin and chitosan depend on the sample characteristics such as 
natural source, preparation method, Mw, and DD. In particular, residual proteins, in chitin and 
chitosan, derived from production methods could cause allergic reactions such as hypersensitivity. 
Biocompatibility is an important issue in the choice of a biomaterial for peripheral nerve 
regeneration or SCI repair. In vitro studies have shown that chitosan exerts biomimetic in the 
peripheral nervous system, allowing neuronal adhesion, differentiation, and growth (Cheng, Cao, 
et al., 2003; Yang et al., 2004). Different blends of chitosan and gelatin cross-linked with genipin 
allow cell adhesion and proliferation of NIH3T3 mouse fibroblasts and S5Y5 neuroblastoma cells. 
Cross-linked samples were found to be biocompatible in particular blends containing 8% gelatin 
supporting very well neuroblastoma cell adhesion and proliferation (Chiono et al., 2008). Among 
different blends of chitosan with polyacrylamide, ethyl acrylate, and hydroxyethyl acrylate, 
chitosan, poly(methyl acrylate), and 50% (w/w) blends of ethyl acrylate and hydroxyethyl acrylate 
were the most suitable polymers to promote in vitro cell adhesion and differentiation of neural 
explants from the medial ganglionic eminence and the cortical ventricular zone of embryonic rat 
brains (Soria et al., 2006). Polymeric biomaterial composite of chitin, chitosan, and gelatin, with a 
pore geometry of inverted colloidal crystals, induced pluripotent stem (iPS) cell adhesion and 
proliferation and has the potential to guide and accelerate differentiation of iPS cells toward a 
neuron phenotype (Kuo & Lin, 2013). It has been also shown that rat pheochromocytoma cell line 
(PC12), grown on chitosan–gelatin–fibronectin-composed films, differentiates more rapidly and 
extends longer neurite than on pure chitosan films (Cheng, Deng, et al., 2003). Another study 
reported that the blending of chitosan with polycaprolactone (PCL) increased cell viability and 
redistribution of actin cytoskeletal fibers of mouse embryonic fibroblasts cultured in vitro 
(Sarasam & Madihally, 2005). 
In addition, biodegradable chitosan microgrooved polymers were successfully used to align 
Schwann cells (SCs) and cells of the glial cell line C6. SCs display high degree of alignment and 
express neurotrophic factors, like glial-derived neurotrophic factor (GDNF) and nerve growth 
factor (NGF; Hsu, Lu, Ni, & Su, 2007). Yuan et al. also reported that chitosan membranes and fibers 
have excellent neuroglial cell affinity and good biological compatibility. SCs grown on chitosan 
membranes displayed a spherical shape, whereas on chitosan fibers, they had an elongated 
morphology (Yuan et al., 2004). Yet, Wang et al. (2009) reported that a chitosan nonwoven 
nanofiber mesh tube with an inner layer of oriented nanofibers, produced by electrospinning 
method, induced alignment of immortalized adult mouse SCs (IMS32). Cells of the rat SCs line RT4-
D6P2T cultured on PCL/chitosan blend nanofibrous scaffold showed higher cell proliferation in 
comparison with cells grown on PCL scaffolds alone and maintained their characteristic cell 
morphology, with spreading bipolar elongation (Prabhakaran et al., 2008). Interestingly, culturing 
adult rat SCs on chitosan films with low acetylation resulted in better cell spreading and 
proliferation (Wenling et al., 2005). Cross-linking agents may also influence the adhesion and 
proliferation of cultured SCs. Cao et al. (2005) showed that HDI cross-linked chitosan films 
enhanced the spread and the proliferation of SCs, whereas ECH and GA cross-linked films delayed 
cell proliferation. Electrical stimulation, through conductive polymers, can be used to enhance 
neurite outgrowth and peripheral nerve regeneration. Conductive polypyrrole chitosan 
membranes have been shown to support SC adhesion, spreading with and without electrical 
stimulation (Huang, Hu, et al., 2010). Interestingly, this study provides confirmation of cell 
biocompatibility on chitosan conductive polymers. Concerning employability of chitosan for neural 
repair, in vitro studies using neural stem cells (NSCs), human adipose-derived stem cells 
(hADSCs),neuroepithelial stemcells(NEPs),andiPS cellshave beencarried out since these cells have a 
great potential as a cell replacement therapy for SCI. Chitosan/collagen membrane showed low 
cytotoxicity supporting rat NSC (at the neurosphere level) survival, proliferation, and 
differentiation. In particular, cells migrate out from the neurospheres and differentiate into 
neurons (Yang, Mo, Duan, & Li, 2010). NSCs have been also cultured on laminin-coated chitosan 
channels (Guo et al., 2012). 
Moreover, chitosan carrier loaded with neurotrophin 3 (NT-3) provided an ideal environment for 
adhesion, proliferation, and differentiation of NSCs (Yang, Duan, Mo, Qiao, & Li, 2010). NSCs 
seeded in fibrin scaffolds within a chitosan channel, containing PLGA microspheres releasing 
dibutyryl cyclic-AMP, differentiate in vitro tob-III-tubulin positive neurons providing further 
confirmation of chitosan scaffold biocompatibility (Kim, Zahir, Tator, & Shoichet, 2011). Yet, 
scaffolds made of chitin, chitosan, and gelatinwith pore geometry of inverted colloidal crystals 
have been successfully used to guide the differentiation of iPS cells into neurons (Kuo & Lin, 2013). 
Finally, hADSCs have been successfully transdifferentiated from mesenchymal into the neural 
lineage onto a chitosan-coated surface (Hsueh, Chiang, Wu, & Lin, 2012). hADSCs are a subset of 
multipotent mesenchymal stem cells with less ethical conflict and minimal invasive surgical 
procedure to obtain cells and can thus be tentatively proposed as agents for promoting nerve 
regeneration in patients. NEPs are NSCs with multipotentiality for neuronal and glial 
differentiation. NEPs have been reported to adhere and grow on chitosan fibers. Moreover, they 
could differentiate into neurons and glia (Fang et al., 2010). This study demonstrated that chitosan 
fibers have good biocompatibility with NEPs. 
2.3. Chitosan surface modification 
Improving nerve cell affinity for chitosan is a key issue for improving its effectiveness for neural 
regeneration (Dhiman, Ray, & Panda, 2004; Haipeng et al., 2000; Zhu, Gao, He, Liu, & Shen, 2003; 
Zielinski & Aebischer, 1994). Combining chitosan with poly-L-lysine, laminin, laminin peptide, or 
collagen may increase cell adhesion, growth, and viability. Blending chitosan with poly-L-lysine 
improved PC12 cell affinity in comparison with chitosan and chitosan–collagen films as 
demonstrated by increasing attachment, growth, and differentiation into nerve cells. The 
increased cell affinity might be due to both the increased surface charge and hydrophilicity of 
composite materials (Mingyu et al., 2004). Another study also reported that poly-L-lysine-, 
collagen-, or albuminblended chitosan exhibit better nerve cell affinity, neurite outgrowth, and 
proliferation of PC12 and fetal mouse celebral cortex cells than original chitosan (Cheng, Cao, et 
al., 2003). 
Thermoresponsive chitosan/glycerophosphate salt hydrogel coated with poly-D-lysine immobilized 
via azidoaniline photocoupling improves cell adhesion and morphology and neurite outgrowth 
compared with uncoated chitosan/glycerophosphatesalt hydrogel(Cromptonetal., 
2007).Increasing poly-D-lysine concentration did not alter cell survival but significantly inhibited 
neurite outgrowth (Crompton et al., 2007). Lamininisan180-
KDaglycoproteinthatplaysanimportantroleinneuronal cell adhesion, differentiation, and neurite 
outgrowth (Madison, da Silva, Dikkes, Sidman, & Chiu, 1987; Manthorpe et al., 1983). Two 
peptides of the lamin-1 molecule, namely, YIGSR (Tyr-Ile-Gly-Ser-Arg) and IKVAV (Ile-Lys-Val-Ala-
Val) sequences, mediate receptor-specific neural cell adhesion and are known to promote cell 
adhesion and neurite outgrowth, respectively (Graf et al., 1987; Kleinman et al., 1988; 
Pierschbacher & Ruoslahti, 1984; Sephel, Burrous, & Kleinman, 1989; Tashiro et al., 1989). 
Moreover, these domains enhance SC migration. Surface modification of a biomaterial may 
improve its biocompatibility. Matsuda et al. developed a new biomaterial consisting of molecularly 
aligned chitosan with IKVAV and 
YIGSRpeptidesbondedcovalently.Briefly,chitosanwasthiolatedbyreacting 4-
thiobutyrolactonewiththechitosanaminogroupandthiolgroupofcysteine 
locatedattheendofthesyntheticlamininpeptidesthatwerereactedchemically with thiolated chitosan 
to form chitosan-S-S-laminin peptide (Matsuda, Kobayashi, Itoh, Kataoka, & Tanaka, 2005). A novel 
chitosan gel has been synthesized by reaction of chitosan amine group with methacrylic 
anhydride, resulting in methacrylamide chitosan (Yu, Kazazian, & Shoichet, 2007). Maleimide-
terminated cell adhesive peptides, mi-GDPGYIGSR and mi-GQASSIKVAV, have been coupled to a 
thiolated form of methacrylamide chitosan, resulting in increased neuronal adhesion and neurite 
outgrowth (Yu et al., 2007). Synthetic surface modification methods often lead to alterations of 
the original material’s physical proprieties. The plasma surface modification 
processhasbeenshowntobeabletomodifythesurfacepropertiesofabiomaterial without affecting its 
bulk physical properties (Yeh, Iriyama, Matsuzawa, Hanson, & Yasuda, 1988). Compared with the 
conventional chemical method, the percentage of laminin incorporated on chitosan films by 
plasma treatment is significantly higher (Huang, Huang, Huang, & Chen, 2007). Moreover, laminin-
modified chitosan membrane significantly increases SC adhesion (Huang et al., 2007). Carbon 
nanotube/chitosan fibers coated with laminin, via an oxygen plasma technique, allowed PC12 cell 
adhesion, growth, and guided oriented neurite outgrowth (Huang et al., 2011). 
Gliosarcoma cells (9 L) and primary neurons have been cultured on chitosan, GA-cross-linked 
chitosan, GA-cross-linked chitosan–gelatin conjugate, a chitosan–gelatin mixture, chitosan coated 
with poly-L-lysine, chitosan coated with laminin, and chitosan coated with serum revealed that 
coated chitosan, especially chitosan coated with laminin, has excellent nerve cell affinity, 
promoted better cell adhesion, spread, and growth in comparison with cross-linked-chitosan or 
chitosan alone (Haipeng et al., 2000). In conclusion, it was shown that chitosan precoated with 
ECM molecules, in particular laminin, improves nerve cell affinity. The ECM molecules adsorbed on 
the materials, and the physicochemical properties of the material improve the adhesion and 
spread of nerve cells on the biomaterials. 
2.4. Chitosan as a tool for neurotrophic factor delivery 
 To enhance axonal regeneration, spatial and temporal delivery of therapeutic molecules 
combined with biomaterials may be helpful. Current methods for therapeutic agent delivery, such 
as oral and intravenous administration, are inadequate for local delivery as they have limitation of 
dose control, premature drug degradation, not specific action, and may lead to undesirable side-
effects and/or system effects. In order to provide a system for local and sustained growth factor 
release, poly-lactide-co-glycide microspheres have been incorporated into chitosan guidance 
channels by spin-coating the interior of a chitosan channel with a chitosan solution containing 
microspheres minimizing the exposure of PLGA microspheres to acidic solution (Kim, Tator, & 
Shoichet, 2008). Alkaline phosphatase, used as a model protein to test the release and bioactivity, 
showed high encapsulation efficiency and bioactivity profile over a 90-day period in vitro (Kim et 
al., 2008). Poly-lactide-co-glycide microspheres have been physically entrapped in between two 
concentric tubes consisting of a chitosan inner tube and a chitin outer tube (Goraltchouk, Scanga, 
Morshead, & Shoichet, 2006). Bovine serum albumin (BSA), used as a model drug, was released up 
to 84 days after encapsulation in the microspheres (Goraltchouk et al., 2006). Epidermal growth 
factor (EGF), coencapsulated with BSA, was released for 56 days with a similar profile to that of 
BSA and was found to be active up to 14 days (Goraltchouk et al., 2006). Moreover, 
microstructured polymer filaments used as a nerve implant have been successfully loaded with 
chitosan/siRNA nanoparticles to promote nerve regeneration and ensure local delivery of 
nanotherapeutics. The nanoparticles were internalized by the cells resulting in target mRNA 
reduction and enhanced neurite outgrowth (Mittnacht et al., 2010). Pfister et al. reported that 
NGF release kinetics could be regulated by embedding NGF at different radial locations within a 
nerve conduit. In particular, polyelectrolyte alginate/chitosan conduit was coated with 
poly(lactide-co-glycolide) to control the release of the embedded NGF (Pfister, Alther, Papaloizos, 
Merkle, & Gander, 2008). A sustained release of NGF in low nanogram concentration per day was 
obtained for up to 15 days in vitro (Pfister et al., 2008). Hydrogels are cross-linked polymers 
characterized by high water content. They can have a possible application as growth factor-
releasing systems. Biodegradable hydrogels made up of oppositely charged polysaccharide 
alginate and chitosan showed high water uptake (84% (w/w)) and permitted good permeation of 
fluorescent-labeled dextran in a molecular-weightdependent manner (Pfister, Papaloizos, Merkle, 
& Gander, 2007). Spatially defined patterns of NGF can be created using photochemical 
immobilization technique made possible by UV confocal laser pattering. NGF has been chemically 
immobilized on chitosan films in distinct areas or as concentration gradients remaining bioactive 
as demonstrated by in vitro culturing of dissociated primary neuron from rat superior cervical 
ganglia. When neurons are plated on a chitosan film characterized by distinct immobilized NGF-
patterned areas surrounded by unmodified chitosan, remained as single spread cells in the NGF-
patterned region and formed clusters resulting in lower cell survival in the unmodified chitosan 
areas. Moreover, the immobilized NGF induces axonal sprouting compared with the unmodified 
chitosan (Yu, Wosnick, & Shoichet, 2008). Finally, a recent study showed that photo-cross-linkable 
streptavidinmodified methacrylamide chitosan 3D hydrogel, along with the recombinant biotin–
interferon-g promotes neuronal differentiation of neuronal stem/progenitor cells (NSPCs, Leipzig, 
Wylie, Kim, & Shoichet, 2011). 
3. CHITOSAN FOR CENTRAL NERVOUS SYSTEM REPAIR 
So far, the potential use of chitosan for central nervous system (CNS) nerve repair has been 
focused on SCI, a common outcome of traffic accidents like motor vehicle crashes, sports injuries, 
and trauma that may lead to life-long paralysis, for which, unfortunately, there is no effective cure. 
In fact, axons of adult mammals regenerate poorly and in a disorganized manner or fail to 
regenerate spontaneously after SCI. When nervous tissue loss occurs, different methods have 
been used to bridge the spinal cord gap. For example, transplantation of peripheral nerves (Bray, 
Villegas-Perez, Vidal-Sanz, & Aguayo, 1987; Cheng, Cao, & Olson, 1996), SCs (Bunge, 2002; 
Novikova, Pettersson, Brohlin, Wiberg, & Novikov, 2008; Xu, Zhang, Li, Aebischer, & Bunge, 1999), 
olfactory ensheathing cells (Li, Field, & Raisman, 1997; Ramon-Cueto, Plant, Avila, & Bunge, 1998), 
and NSCs has been used (Teng et al., 2002; Xue et al., 2012; Zheng & Cui, 2012). These studies 
have shown that CNS axons can regenerate in an appropriate microenvironment and injured axons 
can recover part of their function. However, the above-mentioned methods have limitations for 
clinical applications, such as damage to the donors of peripheral nerves and immunological 
rejection. Biomaterials are becoming increasingly popular as a potential tool for the treatment of 
SCI as a mean to restore the ECM at the site of injury. Various materials, both of natural and 
synthetic origin, have been investigated for potential applications in the spinal cord (Nomura, 
Tator, & Shoichet, 2006; Novikova et al., 2003; Samadikuchaksaraei, 2007; Straley, Foo, & 
Heilshorn, 2010). These materials can support endogenous tissue regeneration (Tysseling-Mattiace 
et al., 2008; Woerly, Pinet, de Robertis, Van Diep, & Bousmina, 2001), promote directed axonal 
regrowth (Li and Hoffman-Kim, 2008; Yoshii, Ito, Shima, Taniguchi, & Akagi, 2009), enhance cell 
transplant survival and integration (Itosaka et al., 2009; Teng et al., 2002), deliver drugs ( Johnson, 
Parker, & Sakiyama-Elbert, 2009; Kang, Poon, Tator, & Shoichet, 2009; Willerth & Sakiyama-Elbert, 
2007), and seal damaged dura mater (Gazzeri et al., 2009). Biomaterials designed for spinal cord 
repair should provoke minimal chronic inflammation and immune responses when implanted into 
the body (Anderson, Rodriguez, & Chang, 2008; Williams, 2008). These responses depend not only 
on the intrinsic properties of the material itself but also on the form in which the material is 
presented, for example, implant shape (Di Vita et al., 2008), size (Kohane et al., 2006), and 
porosity (Ghanaati et al., 2010). In particular, it is important to monitor over time degradation 
kinetics and secondary product formation of biomaterials because degradation products can elicit 
inflammatory responses that may be different than those elicited by the implanted material. 
Regarding degradation kinetics, chitosan is an attractive material because of its degradation rate 
that can be regulated by acting on its DD. Fully deacetylated (DD¼100%) chitosan is 
nondegradable (Freier, Koh, et al., 2005; Tomihata & Ikada, 1997), whereas partially deacetylated 
(DD¼70%) is fully degradable (Kofuji, Ito, Murata, & Kawashima, 2001; Tomihata & Ikada, 1997). In 
recent years, chitosan, either alone or in combination with other biomaterials (Table 1.1), 
adhesion peptides (Table 1.2), supportive cells (Table 1.3), or growth factors (Table 1.4), has been 
widely used for spinal cord repair. Ex vivo and in vivo SCI models demonstrate that chitosan is able 
to restore compromised membrane integrity following spinal cord trauma, reduces injury-
mediated production of reactive oxygen species (ROS), and restricts continuing lipid peroxidation, 
displaying a potent neuroprotective role even though it did not show any ROS, or acrolein, 
scavenging ability (Cho et al., 2010). Yet, the use of chitosan has therapeutic potential through 
site-specific delivery following traumatic spinal cord and head injury (Cho et al., 2010). To increase 
the potential for axonal regeneration and functional recovery, implantation of autograft combined 
with biomaterials appears to be a promisingstrategytoo.Nomura,Baladie,etal.(2008) 
haveshownthatintracavitary implantation of chitosan guidance channels containing peripheral 
nerve grafts after subacute SCI resulted in a thicker bridge containing a larger number of 
myelinated axons compared with chitosan channels alone. Peripheral nervefilled chitosan conduits 
showed an excellent biocompatibility with the adjacent neural tissue with no signs of degradation 
and minimal tissue reaction at 14 weeks after implantation (Nomura, Baladie, et al., 2008). 
3.1. Surface modification of chitosan conduits for CNS repair  
A promising strategy for facilitating nerve regeneration is the combination of biomaterials with 
adhesion molecules (Table 1.2), such as laminin (Cheng et al., 2007; Lemmon, Burden, Payne, 
Elmslie, & Hlavin, 1992), L1 (Lemmon et al., 1992), N-cadherin (Lemmon et al., 1992), and collagen 
(Li et al., 2009). These molecules may be positioned in the inner portion of the tube device in 
order to guide neurite growth. Chitosan conduits enriched with adhesion molecules have been 
already used in vivo with the goal of better directing the repair of damaged axons following SCI. 
Biodegradable porous chitosan nerve conduits, filled with semifluid type I collagen, have been 
developed using lyophilizing and wire-heating process (Li et al., 2009) and implanted into the 
injured spinal cord of a rat model. Results showed that collagen serves as a directional guide to 
facilitate correctly aligned axon regrowth and enhances nerve regeneration across a gap. Yet, the 






In another study, a laminin-coated conduit was shown to enable axons to cross the lesioned area 
of the spinal cord and to reduce glial scar formation (Cheng et al., 2007). Behavioral analyses 
evaluating the Basso–Beattie– Breshnahan motor behavior score, the sensorimotor combined 
behavior score, open-field walking scores, and treadmill analyses demonstrated that following the 
implantation of the laminin-coated nerve conduit the rats showed a tendency toward behavior 
improvement and functional recovery (Cheng et al., 2007). Histological and immunocytochemical 
analyses indicated that the implanted nerve conduit groups were capable of leading the damaged 
axons through the lesioned area without triggering inflammation or apoptosis (Cheng et al., 2007). 
Other cell adhesion molecules, such as L1, have been shown to enhance CNS regeneration, and 
Xuet al., by using the optic nerve transection animal model, showed that polyglycolic acid (PGA)–
chitosan conduits coated with recombinant L1–Fc have a potential role in promoting nerve 
regeneration by guiding axonal regrowth and remyelination (Xu et al., 2004). 
3.2. Chitosan conduits combined with cells for CNS repair  
NSPCs, bone marrow mesnchymal stem cells (BMSCs), and radial glial cells have been used in 
combination with chitosan for SCI repair (Table 1.3). Results showed that, compared to direct 
NSPCs injection, chitosan channels improved their survival after implantation (Bozkurt et al., 2010; 
Guo et al., 2012; Kim et al., 2011). In other studies, NSPCs isolated from the subependyma of 
lateral ventricles of adult green fluorescent protein (GFP) transgenic rat forebrains (Zahir et al., 
2008) or derived from brain or spinal cordoftransgenicGFPrats (Nomura, Zahir, et 
al.,2008)incombinationwith chitosan channels were implanted into the spinal cord after 
transection injury. These in vivo studies showed excellent survival of NSPCs as well as 
differentiation into astrocytes and oligodendrocytes (Nomura, Zahir, et al., 2008; 
Zahiretal.,2008).Moreover,hostneuronswereidentifiedinthetissuebridge that formed within the 
chitosan tubes and bridged the transected cord stumps (Zahir et al., 2008). The excellent in vivo 
survival of the NSPCs coupled with their differentiationand maintenance of host neuronsinthe 
regeneratedtissue bridge demonstrates that the use of three-dimensional chitosan scaffolds 
combined with adult spinal cord-derived NSPCs is a promising therapeutic strategy for stem cell 
delivery and enhances regenerative potential restoring spinal cord function after SCI although 
functional outcome recovery remains poor (Bozkurt et al., 2010; Nomura, Zahir, et al., 2008; Zahir 
et al., 2008). 
BMSCs (Chen et al., 2011; Wang, Wen, Lan, & Li, 2010) and radial glial 
cells(Nomuraetal.,2010),incombination withchitosanscaffold, havebeen successfully used to 
promote SCI repair. 
3.3. Chitosan conduits combined with neurotrophic factors or neuroprotective molecules for CNS 
repair  
Chitosan conduits combined with neurotrophic factors or neuroprotective molecules have been 
used for SCI repair as summarized in Table 1.4. 
Recently,theneuroprotectiveeffectsofAtorvastatin,a drugusedasa cholesterol lowering agent in 
patients, are becoming the focus of many research studies. Interestingly, chitosan microspheres 
containing Atorvastatin calcium have been successfully used to improve the functional outcome in 
an experimental SCI model (Eroglu et al., 2010). Moreover, nogo-66 receptor protein, basic 
fibroblast growth factor (bFGF), EGFs, and platelet-derived growth factor have been successfully 
used in combination with NSPCs for SCI repair (Guo et al., 2012). 
4. CHITOSAN FOR PERIPHERAL NERVOUS SYSTEM REPAIR 
The clinical treatment of large peripheral nerve defects requires bridging the defect that is usually 
accomplished by means of an autologous nerve graft. However, nerve autografting has various 
drawbacks such as sacrificing of a healthy functioning nerve resulting in donor site morbidity, size 
and quality mismatch, and possible neuroma formation at the donor site. Allografts using nerves 
from other individuals or animals require an additional immunosuppressant treatment. Various 
artificial materials have been used as scaffolds for nerve regeneration including chitosan, either 
alone or in combination with other materials. In this context, chitosan is an attractive material 
because of its mechanical strength, porosity, biodegradability, and biocompatibility, and thus, it 
has been recently used for repairing nerve injury, either alone or in combination with other 
biomaterials (Table 1.5), adhesion molecules (Table 1.6), cells (Table 1.7), or growth factors (Table 
1.8). A number of in vivo studies suggested that chitosan conduits are promising candidates as 
supporting material for tissue engineering application in peripheralnervereconstruction(Huang, Lu, 
et al.,2010;Ishikawaet al.,2007;Lauto 
etal.,2007,2008;Marcoletal.,2011;Matsumotoetal.,2010;Pateletal.,2006; Rickett et al., 2011; 
Rosales-Cortes, Peregrina-Sandoval, Banuelos-Pineda, Sarabia-Estrada, et al., 2003; Simoes et al., 
2011; Wang, Itoh, Matsuda, Ichinose, et al., 2008; Wang, Itoh, et al., 2010; Wang et al., 2009; 
Yamaguchi et al., 2003; Zhang et al., 2005). Anexperimentalstudyreconstructing10-
mmgapsintheratsciaticnerve showed that chitosan tubes induce nerve regeneration and are 
gradually degraded and absorbed in vivo (Yamaguchi et al., 2003). Patel et al. (2006) reported that 
chitosan nerve guides improve functional nerve recovery, by increasing axonal growth, reduce 
muscle atrophy, and restore functional strength. It has also been shown that the regeneration of 
the axotomized dog sciatic nerve can be improved through tubulization with chitosan without 
affecting the immune response (Rosales-Cortes, Peregrina-Sandoval, Banuelos-Pineda, Sarabia-
Estrada, et al., 2003). As an internal conduit framework is concerned, a freeze-dried chitosan gel 
sponge has been used to bridge a 8-mm gap lesion in the rat sciatic nerve; 14 daysafterthe 
surgery, the regeneratednerve fibers areextended insidethe conduit along a cell layer provided by 
infiltrating cells, and 2 months postsurgery, the regenerated nerve appeared well remyelinated, 
indicating that the chitosan gel sponge material might be a promising graft for peripheral nerve 
regeneration (Ishikawa et al., 2007). Chitosan nano-/microfiber mesh tubes have been safely used 
also to successfully regenerate damaged thoracic nerves in beagle dogs, specifically sympathetic 
and phrenic nerve, resulting in restoration of the respiratory function (Matsumoto et al., 2010). 
Chitosan nanofibers mesh tubes with or without orientation and bilayered chitosan mesh tubes 
with an inner layer of oriented nanofibers and an outer layer of randomized nanofibers have been 
used to bridge sciatic nerve defects in rats. Sprouting of axons and axonal maturation followed by 
functional recovery occurred in the oriented conduits as well as in the bilayered conduits matching 
the outcome of the nerve autografts (Wang et al., 2009). Nano-/microfiber mesh tubes with a DD 
of 78% or 93% investigated in the 10-mm rat sciatic nerve gap repair resulted in better sensory 
recovery for mesh tubes with a DD of 93%. These tubes have adequate mechanical properties to 
preserve the tubes internal lumen, resulting in better cell migration and adhesion as well as 
humoral permeation enhancing nerve regeneration (Wang, Itoh, Matsuda, Ichinose, et al., 2008). 
Interestingly, a chitosan-based-laser-activated adhesive has been successfully applied to perform 
sutureless coaptation of the rat tibial nerve without altering axon number and morphology (Lauto 
et al., 2007, 2008). A photocrosslinkable hydrogel based on chitosan has been in vitro successfully 
characterized and proposed as a new adhesive for peripheral nerve anastomosis (Rickett et al., 
2011). Chitosan has further been used in combination with other biomaterials for bridging 
peripheral nerve gaps (Fan et al., 2008; Gu et al., 2012; Jiao et al., 2009; Lin et al., 2008; Liu et al., 
2011; Simoes et al., 2010; Wang et al., 2005; Xie et al., 2005; Xie et al., 2008; Xu et al., 2009). 
Chitosan– polylactid acid (PLA) composite nerve conduits showed good biocompatibility and 
permeability, good mechanical strength, intensity, and elasticity, facilitating microsuture 
manipulation, and they provide enough mechanical strength to support nerve regeneration. 
Chitosan–PLA conduits promoted axonal regeneration of rat sciatic nerves across a defect of 10 
mm, with comparable success to nerve autografts, resulting in muscle reinnervation 12 weeks 
postsurgery (Xie et al., 2008). Yet, tubular grafts made out of chitosan membranes have been 
successfully used to improve peripheral nerve functional recovery after neurotmesis of the rat 
sciatic nerve, and they induced better nerve regeneration and functional recovery when compared 
with poly-lactic-polyglycolic acid (PLGA) control tubes (Simoes et al., 2010). A dual component 
artificial nerve conduit consisting of an outer chitosan microporous conduit and an internal 
oriented PGA filament matrix has been used to bridge a 10-mm defect in rats after long-term 
delay (3 or 6 months), resulting in reinnervation of the atrophic denervated muscle by 
regenerating neurites through new muscle–nerve connections (Jiao et al., 2009). The same conduit 
has been used to regenerate 30-mm beagle dog sciatic nerve defects, resulting in reconstruction 
and restoration of nerve continuity and functional recovery as indicated by improved locomotion 
activities of the operated limb after target muscle reinnervation (Wang et al., 2005). Finally, a 
couple of clinical studies in which chitosan scaffolds have been used to repair peripheral nerve 
have been reported. Chitosan/PGA artificial conduits have been successfully used in repairing a 35-
mm-long median nerve defect of a human patient. During the 3-year follow-up period, an ongoing 
motor and sensory functional recovery postimplantation was detected (Fan et al., 2008). 
Chitosan/PGA conduits have further been used to repair a 30-mm long median nerve defect in the 
right distal forearm of a 55-year-old male patient. Thirty-six months after the surgery, 
reproducible compound muscle action potentials have been recorded on the right abductor 
policies, the palm adduction of the thumb, and the thumb-index digital opposition recovered and 
facilitated the accomplishment of fine activities (Gu et al., 2012). These results are very promising 
and suggest that the chitosan/PGA artificial nerve graft could be used for clinical reconstruction of 












4.1. Surface modification of chitosan conduits for PNS repair 
 Various studies have been dedicated to develop scaffolds with an inner structure mimicking the 
nerve-guiding basal lamina present in nerve autografts. Designing biomaterial surfaces in order to 
mediate cellular interactions through coupling of specific cell membrane receptors may allow to 
control cell adhesion, cell migration, and tissue organization and consequently improve SC 
migration and organization and axonal outgrowth. To enhance nerve regeneration, a number of 
studies, in which laminin has been used to coat the inner tube surface, have been reported 
(Madison, da Silva, Dikkes, Chiu, & Sidman, 1985; Yoshii, Yamamuro, Ito, & Hayashi, 1987). 
Although these studies proved the effectiveness of scaffold enrichment with laminin, this molecule 
is not easy to synthesize and it cannot be applied in human patients because it is a tumor-inducing 
material (Timpl et al., 1979). To avoid these limitations, laminin peptides (YIGSR and IKVAV) have 
been used for functionalizing the inner surface of chitosan-based conduits too, with the goal of 
improving nerve regeneration. YIGSR-treated chitosan–hydroxyapatite (HAp) tubes enhanced SC 
migration and longdistance growth of regenerated axons in a 15-mm gap rat sciatic nerve injury 
modelincomparisonwithfull laminin-1-coatedchitosantubes.Histological regeneration, as well as 
mechanical properties, of the YIGSR-treated chitosan–HAp tubes matched with those of nerve 
autografts, although functional recovery was delayed (Itoh, Yamaguchi, et al., 2003). Yet, circular 
and triangular cross-section chitosan tubes combined with YIGSR and IKVAV have been used to 
bridge a 15-mm gap in the sciatic nerve of rats. The mechanical strength of triangular tubes was 
higher than that of circular tubes and their inner volume tended to be larger. Again, YIGSR and 
IKVAV matched the effectiveness of full laminin to enhance nerve regeneration (Itoh, Suzuki, et al., 
2003; Suzuki et al., 2003). In another study, thiolated and nonthiolated HAp-coated crab tendon 
triangular cross-section chitosan tubes, both alone and conjugated with the YIGSR peptide, have 
been utilized to bridge a 15-mm rat sciatic nerve gap. Histological and functional recovery analyses 
showed that while thiolation might have delayed nerve tissue regeneration, YIGSR peptides 
enhanced nerve regeneration by promoting sprouting from the proximal nerve stump and long-
distance growth of regenerated axons throughout the tube (Itoh et al., 2005). Moreover, a 
bilayered chitosan tube that comprised of an outer layer of a chitosan film and an inner layer of a 
nonwoven chitosan nano-/microfiber mesh coated with the YIGSR peptide (in which a glycin 
spacer has been introduced) has been successfully used to bridge the 15-mm rat sciatic nerve gap 
(Wang, Itoh, Matsuda, Aizawa, et al., 2008). Chitosan has also been used in combination with 
collagen for nerve repair. Collagen-blended chitosan nerve guides have been successfully tested in 
vivo in rats and enhanced both motor and sensory recoveries in comparison with unblended nerve 
guides (Patel et al., 2008a; Wei, Lao, & Gu, 2003).Moreover,collagen–chitosannerve 
guidespromoteandsupportaxonal sprouting, increase axon diameters and the area occupied by 
regenerated axons, and further improve axonal maturation (Patel et al., 2008b). Collagen–chitosan 
conduits, characterized by longitudinally orientated microchannels, have also been shown to allow 
good nerve regeneration and functional recovery across 15-mm-long rat sciatic nerve defects (Hu 
et al., 2009). A summary of the different studies of chitosan combined with adhesion molecules is 
reported in Table 1.6. 
4.2. Chitosan conduits combined with cells for PNS repair  
Directing SC migration by biomaterial substrates is receiving much attention in peripheral nerve 
tissue engineering (Heath & Rutkowski, 1998). SCs secrete neurotrophic factors and express cell 
adhesion molecules that enhance peripheral nerve regeneration (Gravvanis et al., 2004; Heath & 
Rutkowski, 1998; Ide, 1996). They form an endoneurial sheath which acts as a guide for axonal 
growth from the proximal to the distal nerve stumps. They also play a role in clearing debris and 
creating an appropriate milieu for nerve regrowth. Due to their role in nerve regeneration, the 
behavior of SCs on a biomaterial used for nerve conduit fabrication is clearly a key issue (Guenard, 
Kleitman, Morrissey, Bunge, & Aebischer, 1992; Heath & Rutkowski, 1998) and it has been shown 
that SCs can be aligned by culturing them on biomaterial surface groves which provide 
micrometric dimensions (Hsu et al., 2007; Wang et al., 2009). 
Another strategy to support SC colonization inside nerve guides is preenrichment of the conduit 
with SCs or their precursors. BMSC-derived SCs have been used in combination with chitosan 
conduits to repair 12-mm rat sciatic nerve gap, resulting in nerve conduction velocities, average 
regenerated myelin area, and number of myelinated axons similar to those conduits treated with 
sciatic nerve-derived SCs (Ao et al., 2011). Chitosan-based conduits combined with autologous 
BMSCs have been successfully utilized to bridge 8-mm-long sciatic nerve defects in adult rats 
(Zheng & Cui, 2012). Chitosan/PLGA-based neuronal scaffolds, in which autologous BMSCs have 
been incorporated, promoted dog sciatic nerve regeneration and functional recovery across 50- to 
60-mm-long gaps. The outcome was close to that of nerve autografts and better than that of 
chitosan/PLGA-based scaffolds alone (Ding et al., 2010; Xue et al., 2012). Very recently, 
chitosan/PLGA nerve grafts combined with autologous BMSCs have been utilized to bridge 50-
mm-long medial nerve defects in rhesus monkeys. Functional recovery was more efficient when 
chitosan/ PLGA nerve grafts were combined with BMSCs instead of the used cell-free 
chitosan/PLGA grafts. Moreover, blood tests and histopathological examinations demonstrated 
that BMSCs could be safely used in primates (Hu et al., 2013). Recently, combination ofpeptide 
and cellsto enhance nerve regeneration has been used to bridge 10-mm gaplesionin rat sciatic 
nerve.Laminin-coated chitosan conduit in combination with BMSCs results in enhancement of 
nerve regrowth, muscle mass maintaining, and functional recovery. BMSCs 
inhibitedneuronalcelldeathandoverturntheinflammatoryresponseinduced by long-term chitosan 
implantation promoting nerve regeneration (Hsu et al., 2013). Chitosan 3-glycidoxypropyl-
methyldiethoxysilane-cross-linked membranes have been used for peripheral nerve reconstruction 
in the rat sciatic nerve model, either alone or in combination with N1E-115 NSCs. Chitosan 
membranes showed good biocompatibility and were suitable for N1E-115 cells growth. However, 
the study of in vivo nerve regeneration after nerve crush injury showed that freeze-dried chitosan 
membrane without cell enrichment improved axonal regrowth and functional recovery, suggesting 
that nerve enwrapping with chitosan membrane alone may be an effective method for improving 
peripheral nerve repair, while enrichment with N1E-115 neural cells is not (Amado et al., 2008; 
Simoes et al., 2011). 
4.3. Chitosan conduits combined with neurotrophic factors or neuroprotective molecules for 
PNS repair  
After an injury, one of the causes contributing to apoptosis and poor functional recovery is the 
neurotrophic factor deprivation (Ramer, Priestley, & McMahon, 2000). Nerve regeneration has 
been found to be enhanced by utilizing guidance channels filled with neurotrophic factors, such as 
GDNF, ciliary nerotrophic factor (CNTF), FGF-2, and NT-3 (Grothe, Haastert, & Jungnickel, 2006; 
Madduri, Feldman, Tervoort, Papaloizos, & Gander, 2010; Madduri, Papaloizos, & Gander, 2010; 
Oh et al., 2008; Pfister et al., 2008; Yang et al., 2007). Various types of nerve guides have been 
developed by blending chitosan with different growth factors (Table 1.8). Adding growth factors 
can support nerve regeneration by improving the biological properties of a nerve guide. GDNF has 
been mixed to chitosan–lamininconduitswhichhavebeenusedtobridge10-mmratsciatic nerve gaps. 
GDNF–laminin-blended chitosan conduits increased functional recovery and decreased muscle 
atrophy compared with unblended chitosan conduits (Patel et al., 2007). Histologically, the GDNF–
laminin-blended chitosan conduits demonstrated at 6 weeks postsurgery regenerated axons with 
higher axonal area and myelination in comparison with control conditions. At 9–12 weeks 
postsurgery, however, control groups matched the GDNF–laminin-blended chitosan group 
indicating that these kinds of conduits exert their positive effectsduring the initial stages of nerve 
regeneration only (Patel et al., 2009). In another study, CNTF-coated PLGA chitosan nerve conduit 
has been utilized to repair 25-mm-long segments in the canine tibial nerve. Histological results 
demonstrated that the PLGA/chitosan–CNTF conduits were capable of guiding the damaged axons 
through the lesioned area, resulting in good functional recovery close to the outcome in the nerve 
autograft group (Shen et al., 2010). Yet, also NGF has been immobilized onto biodegradable 
PDLLA/CS/ CHS nontoxic nerve conduits, resulting in good functional recovery after bridging 10-
mm defects in the rat sciatic nerve (Xu et al., 2011). Moreover, chitosan conduit on which NGF was 
immobilized via genipin cross-linking resulted in nerve reconstruction and muscle reinnervation in 
a 10-mm-long sciatic nerve gap in rat (Wang et al., 2012). Chitosan nerve conduits filled with 
heparin-incorporated fibrin– fibronectin matrix for bFGF delivery have been successfully used to 
repair sciatic nerve defects of 10-mm in adult rats (Han et al., 2010). 
Interestingly, a couple of studies showed that chitooligosaccharides (COSs), the biodegradation 
products of chitosan, promote peripheral nerve regeneration and functional recovery in the rat 
sciatic nerve crush injury model and rabbit common peroneal nerve crush injury model, suggesting 
their potential application in peripheral nerve repair as neuroprotective agents (Gong et al., 2009; 
Jiang et al., 2009). Moreover, immunophilin FK506 combined with biodegradable chitosan guide 
provides neurotrophic and neuroprotective actions, promoting nerve regeneration in a rat sciatic 
nerve defect model (Li et al., 2010). Also neurosteroids, such as progesterone (PROG) and 
pregnenolone (PREG), have been used for potentiating conduit nerve repair as these hormones 
are synthesized by SCs (Baulieu & Schumacher, 2000) and induce myelination binding on 
intracellular receptors which activate the synthesis of myelin protein P0 and PMP22 (Desarnaud et 
al., 1998; Jung-Testas, Schumacher, Robel, & Baulieu, 1996). Furthermore, neurite outgrowth may 
be stimulated by a PROG metabolite (5-a-tetrahydroprogesterone) through GABA(A) receptors 
(Guennoun et al., 2001; Koenig, Gong, & Pelissier, 2000). Chitosan conduits have been used to 
deliver PROG into a 10-mm rabbit facial nerve gap model. The released PROG promoted nerve 
regenerationtoa highdegreesothatat45 dayspostsurgerymyelinated fibers were observed both in 
the proximal and distal nerve stumps (ChavezDelgado et al., 2003). Similar results have been 
reported using axotomized dog sciatic nerve injured model (Rosales-Cortes, Peregrina-Sandoval, 
Banuelos-Pineda, Castellanos-Martinez, et al., 2003). Chitosan tubes delivering a combination of 
PROG and PREG have also been tested. Fifteen days postsurgery, the regenerating tissue 
contained SCs holding nonmyelinated fibers, whereas at 45 days postsurgery, the regenerating 
tissue displayed myelinated fibers of different shape, size, and myelin sheath thickness (Chavez-
Delgado et al., 2005). These findings indicate that chitosan conduits allows regeneration of nerve 
fibers and that long-time release of neurosteroid from the conduits induces faster regeneration. 
5. CONCLUSION 
Among the many different types of biomaterials that have been proposed as optimal candidates 
for neural repair scaffolds, chitosan has been receiving growing interests among basic and clinical 
scientists. In this review, we have overviewed the more relevant articles demonstrating that this 
biomimetic material exerts a positive effect on cell cultures of both neurons and glial cells. Yet, 
experimental results obtained from several animal models in vivo and first data from the first few 
clinical studies which were done so far have shown that chitosan-based scaffolds are good 
candidates for developing innovative devices for neural repair of both the CNS and PNS. 
 
Figure 1.1 Summary of the most common chitosan-blend materialsusedfor the fabrication ofnervegraft devices.In 
general, basic materials are composed of (A)chitosan in 
differentdegreesofacetylationtotailortheirrateofbiodegradabilityorchitosan-blendedwith, 
forexample,polyglycolicacid(PGA)(B),polylactidacid(PLA),orothercommonlyusedpolymers.Also,blendsofchitosanwithm
orethanonepolymerhavebeendescribed,forexample, PGA and PLA (C). Chitosan-based materials can further be 
modified at their surfaces which will be in contact to the regenerating neural tissue: extracellular matrix glycoproteins-
like laminin (D) or laminin-derived peptides can be added as an collagen (E) or diverse neurotrophic factors (F), like 
NGF, GDNF, CNTF, or NT-3. The inner surfaces 
oftheguidancechannelscanbemanufacturedtoallowseedingofregeneration-supporting 
celltypes,likealignedSchwanncells(G)ordifferenttypesofstemcells(H).Finally,theinnovativeelectrospinning technique 
canbe utilized to secondary structure the surface of the chitosan-based materials byadding oriented nano- or 
microfibers (I). 
Chitosan is biocompatible, biodegradable, and its chemicophysical properties can be easily 
manipulated with the goal to create scaffolds with different structural features (i.e., 
biodegradation time or surface properties). Figure 1.1 summarizes the most cited chitosan and 
chitosan-blend nerve conduits (Fig. 1.1A–C) as well as the most frequently investigated surface 
modifications of chitosan-based nerve conduits (Fig. 1.1D–I). After reviewing the literature 
regarding the use of chitosan in neural repair approaches, it can be foreseen that the time for 
clinical trials utilizing chitosan-based nerve regeneration-promoting devices is approaching quickly. 
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